Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease

Stem Cell Research and Therapy

Volumn 5, Issue 3, 2014, Pages

  Salama, Hosny ^a   Zekri, Abdel Rahman N ^b   Medhat, Eman ^a   Al Alim, Shereen A ^a   Ahmed, Ola S ^b   Bahnassy, Abeer A ^c   Lotfy, Mai M ^b   Ahmed, Rasha ^a   Musa, Sherief ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c NATIONAL CANCER INSTITUTE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; BILIRUBIN; PROCOLLAGEN; PROCOLLAGEN III C TERMINAL PEPTIDE; PROCOLLAGEN III N TERMINAL PEPTIDE; PROTHROMBIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; ASCITES; AUTOLOGOUS STEM CELL TRANSPLANTATION; CHILD PUGH SCORE; CLINICAL ARTICLE; CONTROLLED STUDY; EGYPT; END STAGE LIVER DISEASE; FEMALE; HEMATEMESIS; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER FIBROSIS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MORTALITY; PERIPHERAL VEIN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STEM CELL MOBILIZATION; ADULT STEM CELL; AUTOTRANSPLANTATION; BONE MARROW CELL; COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; MIDDLE AGED; PROCEDURES; TRANSPLANTATION; VIROLOGY; YOUNG ADULT;

HEPATITIS C VIRUS;

ADULT; ADULT STEM CELLS; BONE MARROW CELLS; EGYPT; END STAGE LIVER DISEASE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEPATITIS C; HUMANS; INFUSIONS, INTRAVENOUS; LIVER CIRRHOSIS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS; YOUNG ADULT;

EID: 84904055020     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt459     Document Type: Article

References (31)

1. Molecular prognostic profile of Egyptian HCC cases infected with hepatitis C virus. Zekri AR, Hassan ZK, Bahnassy AA, Sherif GM, ELdahshan D, Abouelhoda M, Ali A, Hafez MM, Asian Pac J Cancer Prev 2012 13 5433 5438
2. Muscle regeneration by bone marrow-derived myogenic progenitors. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F, Science 1998 279 1528 1530 (Pubitemid 28217075)
3. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Kopen GC, Prockop DJ, Phinney DG, Proc Natl Acad Sci U S A 1999 96 10711 10716 (Pubitemid 29442209)
4. Bone marrow as a potential source of hepatic oval cells. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, Boggs SS, Greenberger JS, Goff JP, Science 1999 284 1168 1170 (Pubitemid 29288406)
5. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, Yokoyama Y, Uchida K, Yamasaki T, Fujii Y, Okita K, Sakaida I, Stem Cells 2006 24 2292 2298 (Pubitemid 44527483)
6. Regenerative medicine for liver disease. Ogawa S, Miyagawa S, Surg Today 2009 39 1019 1025
7. In vitro hepatic differentiation of human mesenchymal stem cells. Lee KD, Kuo TK, Whang-Peng J, Chung YF, Lin CT, Chou SH, Chen JR, Chen YP, Lee OK, Hepatology 2004 40 1275 1284 (Pubitemid 39657001)
8. Pluripotency of mesenchymal stem cells derived from adult marrow. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM, Nature 2002 418 41 49 (Pubitemid 34742565)
9. Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease. Salama H, Zekri AR, Bahnassy AA, Medhat E, Halim HA, Ahmed OS, Mohamed G, Al Alim SA, Sherif GM, World J Gastroenterol 2010 16 5297 5305
10. Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases. Salama H, Zekri AR, Zern M, Bahnassy A, Loutfy S, Shalaby S, Vigen C, Burke W, Mostafa M, Medhat E, Alfi O, Huttinger E, Cell Transplant 2010 19 1475 1486
11. Miltenyi Biotec Company. [ https://www.miltenyibiotec.com/en/ ]
12. Prognostic models including the Child-Pugh, MELD and Mayo risk scores: where are we and where should we go? Christensen E, J Hepatol 2004 41 344 350 (Pubitemid 39177643)
13. Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats. Piscaglia C, Shupe TD, Oh S, Gasbarrini A, Petersen BE, Gastroenterology 2007 133 619 631 (Pubitemid 47187344)
14. Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Pai M, Zacharoulis D, Milicevic MN, Helmy S, Jiao LR, Levicar N, Tait P, Scott M, Marley SB, Jestice K, Glibetic M, Bansi D, Khan SA, Kyriakou D, Rountas C, Thillainayagam A, Nicholls JP, Jensen S, Apperley JF, Gordon MY, Habib NA, Am J Gastroenterol 2008 103 1952 1958
15. Granulocyte colony-stimulating factor receptor: stimulating granulopoiesis and much more. Liongue C, Wright C, Russell AP, Ward AC, Int J Biochem Cell Biol 2009 41 2372 2375
16. G-CSF mobilized PBMCS contribute to the liver function of cirrhotic rats. Yan L, Xu S, Wang S, Wu B, EXCLI J 2010 9 67 75
17. Nitric oxide promotes caspase-independent hepatic stellate cell apoptosis through the generation of reactive oxygen species. Langer DA, Das A, Semela D, Kang-Decker N, Hendrickson H, Bronk SF, Katusic ZS, Gores GJ, Shah VH, Hepatology 2008 47 1983 1993 (Pubitemid 351945565)
18. Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo. Jiang JX, Venugopal S, Serizawa N, Chen X, Scott F, Li Y, Adamson R, Devaraj S, Shah V, Gershwin ME, Friedman SL, Török NJ, Gastroenterology 2010 139 1375 1384
19. Heat shock protein 90 inhibitor induces apoptosis and attenuates activation of hepatic stellate cells. Myung SJ, Yoon JH, Kim BH, Lee JH, Jung EU, Lee HS, J Pharmacol Exp Ther 2009 330 276 282
20. Active matrix metalloproteinase-2 promotes apoptosis of hepatic stellate cells via the cleavage of cellular N-cadherin. Hartland SN, Murphy F, Aucott RL, Abergel A, Zhou X, Waung J, Patel N, Bradshaw C, Collins J, Mann D, Benyon RC, Iredale JP, Liver Int 2009 29 966 978
21. Chimeric analysis of fibroblast growth factor receptor-1 (Fgfr1) function: a role for FGFR1 in morphogenetic movement through the primitive streak. Ciruna BG, Schwartz L, Harpal K, Yamaguchi T, Rossant J, Development 1997 124 2829 2841 (Pubitemid 27354829)
22. Scatter factor/hepatocyte growth factor is essential for liver development. Schmidt C, Bladt F, Goedecke S, Brinkmann V, Zschiesche W, Sharpe M, Gherardi E, Birchmeier C, Nature 1995 373 699 702
23. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Bladt F, Riethmatcher D, Isenmann S, Aguzzi A, Birchmeier C, Nature 1995 376 768 771
24. Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Furge KA, Zhang YW, Vande Woude GF, Oncogene 2000 19 5582 5589
25. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Son BR, Marquez-Curtis LA, Kucia M, Wysoczynski M, Turner AR, Ratajczak J, Ratajczak MZ, Janowska-Wieczorek A, Stem Cells 2006 24 1254 1264 (Pubitemid 44464694)
26. Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. Potian JA, Aviv H, Ponzio NM, Harrison JS, Rameshwar P, J Immunol 2003 171 3426 3434 (Pubitemid 37254543)
27. Identification of cytokines involved in hepatic differentiation of mBM-MSCs under liver-injury conditions. Dong XJ, Zhang H, Pan RL, Xiang LX, Shao JZ, World J Gastroenterol 2010 16 3267 3278
28. Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Gordon MY, Levicar N, Pai M, Bachellier P, Dimarakis I, Al-Allaf F, M'Hamdi H, Thalji T, Welsh JP, Marley SB, Davies J, Dazzi F, Marelli-Berg F, Tait P, Playford R, Jiao L, Jensen S, Nicholls JP, Ayav A, Nohandani M, Farzaneh F, Gaken J, Dodge R, Alison M, Apperley JF, Lechler R, Habib NA, Stem Cells 2006 24 1822 1830 (Pubitemid 44474196)
29. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. Lyra AC, Soares MB, da Silva LF, Fortes MF, Silva AG, Mota AC, Oliveira SA, Braga EL, de Carvalho WA, Genser B, dos Santos RR, Lyra LG, World J Gastroenterol 2007 13 1067 1073 (Pubitemid 46511008)
30. Embryonic stem cells reduce liver fibrosis in CCl4-treated mice. Moriya K, Yoshikawa M, Ouji Y, Saito K, Nishiofuku M, Matsuda R, Ishizaka S, Fukui H, Int J Exp Pathol 2008 89 401 409
31. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Bagheri M, Bashtar M, Ghanaati H, Baharvand H, Ghavamzadeh A, Malekzadeh R, Arch Iranian Med 2007 10 459 466 (Pubitemid 350001896)